Latest Period
Q1 2026
Security Snapshot
AbbVie Inc. - Common Stock (ABBV) Institutional Ownership
CUSIP: 00287Y109
13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026
Institutions Reporting
4,033
Shares (Excl. Options)
1,295,311,927
Price
$217.49
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- ABBV on NYSE
- Shares outstanding
- 1,769,960,826
- Reported price per share
- $205.03
- Price from insider filings
- $205.03
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 1,295,311,927
- Total reported value
- $281,376,732,554
- Portfolio coverage rank
- 0.24%
- Share change
- -21,538,858
- Value change
- -$5,050,577,732
- Number of holders
- 4,033
Security identity
2 facts
Issuer context
3 facts
Latest holder snapshot
7 facts
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- ABBV - AbbVie Inc. - Common Stock is tracked under CUSIP 00287Y109.
- 4033 institutions reported positions in Q1 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 4,126 to 4,033 between Q4 2025 and Q1 2026.
- Reported value moved from $300,924,401,130 to $281,376,732,554.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 4033 institutions filings for Q1 2026.
Security key
00287Y109
Latest holder period
Q1 2026
13F holders
4,033
13D/G owners
1
CIK / CUSIP context first
Open Q1 2026 holders
ABBV full holder history
AbbVie Inc. SEC filings
AbbVie Inc. company facts
AbbVie Inc. insider transactions
AbbVie Inc. 13D/G history
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 00287Y109:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
ABBV
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 7.5% | $28,909,653,374 | 132,924,058 | Vanguard Capital Management | 31 Mar 2026 |
As of 31 Mar 2026, 4,033 institutional investors reported holding 1,295,311,927 shares of AbbVie Inc. - Common Stock (ABBV). This represents 73% of the company’s total 1,769,960,826 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
46%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 8.5% | 150,698,125 | -0.32% | 0.58% | $32,775,334,997 |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.5% | 114,880,324 | 0% | 0.62% | $24,985,321,667 |
| STATE STREET CORP | 4.6% | 81,217,516 | +0.34% | 0.61% | $17,663,997,555 |
| JPMORGAN CHASE & CO | 3.2% | 56,741,691 | +8.3% | 0.82% | $12,092,789,708 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.8% | 49,523,078 | 0% | 0.56% | $10,770,774,234 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.6% | 46,737,581 | +4.7% | 0.63% | $10,142,501,458 |
| MORGAN STANLEY | 2.1% | 38,016,774 | -5.1% | 0.5% | $8,268,268,958 |
| Capital Research Global Investors | 1.8% | 31,254,786 | +23% | 1.1% | $6,797,322,062 |
| BANK OF AMERICA CORP /DE/ | 1.4% | 23,936,943 | -7.3% | 0.38% | $5,206,045,739 |
| FMR LLC | 1.2% | 21,762,703 | -3.7% | 0.25% | $4,733,170,285 |
| NORTHERN TRUST CORP | 1.2% | 21,211,382 | -2.4% | 0.61% | $4,613,263,471 |
| Capital World Investors | 0.9% | 15,841,367 | +21% | 0.47% | $3,445,020,816 |
| GOLDMAN SACHS GROUP INC | 0.86% | 15,145,279 | +17% | 0.43% | $3,293,946,840 |
| FRANKLIN RESOURCES INC | 0.82% | 14,552,069 | -2.2% | 0.78% | $3,164,929,097 |
| Capital International Investors | 0.81% | 14,418,993 | +23% | 0.73% | $3,134,841,523 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.8% | 14,161,606 | +9.6% | 0.64% | $3,080,007,690 |
| UBS Group AG | 0.79% | 14,051,196 | +33% | 0.54% | $3,055,994,618 |
| Bank of New York Mellon Corp | 0.75% | 13,278,161 | -1.6% | 0.53% | $2,887,867,387 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.73% | 13,003,989 | +32% | 0.33% | $2,828,239,000 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.73% | 12,967,398 | -48% | 0.43% | $2,819,978,730 |
| Legal & General Group Plc | 0.69% | 12,159,427 | +0.22% | 0.61% | $2,644,553,778 |
| Nuveen, LLC | 0.63% | 11,115,159 | +29% | 0.65% | $2,417,435,938 |
| AMERIPRISE FINANCIAL INC | 0.63% | 11,068,310 | +10% | 0.56% | $2,406,702,702 |
| Amundi | 0.6% | 10,698,095 | +2.4% | 0.63% | $2,326,728,131 |
| VANGUARD FIDUCIARY TRUST CO | 0.58% | 10,199,396 | 0% | 0.56% | $2,218,266,636 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
49
Latest
Q1 2026
Rows shown
1-25 of 49
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 1,295,311,927 | $281,376,732,554 | -$5,050,577,732 | $217.49 | 4,033 |
| 2025 Q4 | 1,317,892,847 | $300,924,401,130 | +$9,339,898,084 | $228.49 | 4,126 |
| 2025 Q3 | 1,270,015,568 | $293,795,490,662 | -$3,123,583,240 | $231.54 | 3,878 |
| 2025 Q2 | 1,287,075,518 | $238,891,433,790 | +$4,866,082,603 | $185.62 | 3,742 |
| 2025 Q1 | 1,261,493,107 | $264,023,235,689 | -$2,130,141,483 | $209.52 | 3,780 |
| 2024 Q4 | 1,275,092,654 | $226,558,537,921 | +$1,209,556,751 | $177.70 | 3,709 |
| 2024 Q3 | 1,263,246,128 | $249,268,364,641 | +$88,413,171 | $197.48 | 3,466 |
| 2024 Q2 | 1,262,725,926 | $216,474,972,193 | +$1,915,850,329 | $171.52 | 3,339 |
| 2024 Q1 | 1,253,088,393 | $227,875,219,935 | +$2,788,759,396 | $182.10 | 3,353 |
| 2023 Q4 | 1,239,748,668 | $192,192,568,041 | +$1,517,401,072 | $154.97 | 3,297 |
| 2023 Q3 | 1,228,903,942 | $183,197,476,249 | +$1,009,113,820 | $149.06 | 3,092 |
| 2023 Q2 | 1,221,315,614 | $164,787,374,519 | -$1,664,070,544 | $134.73 | 3,053 |
| 2023 Q1 | 1,233,425,991 | $196,519,460,228 | +$259,081,467 | $159.37 | 3,117 |
| 2022 Q4 | 1,235,502,434 | $199,621,628,438 | +$2,752,393,686 | $161.61 | 3,144 |
| 2022 Q3 | 1,221,220,466 | $164,097,646,774 | +$170,284,213 | $134.21 | 2,949 |
| 2022 Q2 | 1,217,745,031 | $186,477,353,594 | +$3,489,007,770 | $153.16 | 2,980 |
| 2022 Q1 | 1,203,308,144 | $195,040,563,504 | +$2,450,810,000 | $162.11 | 3,033 |
| 2021 Q4 | 1,188,323,728 | $160,862,723,207 | +$1,040,998,406 | $135.40 | 2,954 |
| 2021 Q3 | 1,177,170,536 | $127,005,644,713 | -$384,320,770 | $107.87 | 2,641 |
| 2021 Q2 | 1,182,050,895 | $133,115,260,852 | -$647,210,591 | $112.64 | 2,657 |
| 2021 Q1 | 1,186,224,948 | $128,344,178,557 | -$1,087,268,478 | $108.22 | 2,595 |
| 2020 Q4 | 1,197,885,694 | $128,301,295,744 | -$1,070,454,735 | $107.15 | 2,580 |
| 2020 Q3 | 1,210,244,308 | $105,941,681,033 | -$1,507,877,911 | $87.59 | 2,356 |
| 2020 Q2 | 1,226,149,387 | $120,286,919,217 | +$14,394,795,664 | $98.18 | 2,397 |
| 2020 Q1 | 1,079,313,793 | $82,241,542,825 | +$791,234,318 | $76.19 | 2,213 |